An Evaluation of Sumatriptan-Naproxen (Treximet) in the Treatment of Acute Migraine Headache: A Placebo Controlled, Double Blind, Crossover Study Assessing Cognitive Function

被引：0
|
作者：
Edwards, K. R. [1 ,2 ]
Rosenthal, B. [1 ]
Farmer, K. [3 ]
Cady, R. [3 ,4 ]
Browning, R. [3 ]
机构：
[1] Empire Neurol, Neurol, Latham, NY USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Headache Care Ctr, Springfield, MO USA
[4] Clinvest Inc, Neurol, Springfield, MO USA
来源：
HEADACHE | 2011年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial
    Xing, Dante
    Yoo, Choongsung
    Gonzalez, Drew
    Jenkins, Victoria
    Nottingham, Kay
    Dickerson, Broderick
    Leonard, Megan
    Ko, Joungbo
    Faries, Mark
    Kephart, Wesley
    Purpura, Martin
    Jaeger, Ralf
    Wells, Shawn D.
    Sowinski, Ryan
    Rasmussen, Christopher J.
    Kreider, Richard B.
    NUTRIENTS, 2021, 13 (12)
  • [42] Double-Blind, Placebo-Controlled, Crossover Study of Early-Intervention With Sumatriptan 85/Naproxen Sodium 500 in (Truly) Episodic Migraine: What's Neck Pain Got To Do With It?
    Calhoun, Anne H.
    Ford, Sutapa
    POSTGRADUATE MEDICINE, 2014, 126 (02) : 86 - 90
  • [43] Almotriptan for acute treatment of migraine: a randomized, double-blind, placebo-controlled study in Korea
    Chung, C. S.
    Park, K. Y.
    Moon, H. S.
    Joo, S. A.
    Song, K. S.
    Kim, J. A.
    CEPHALALGIA, 2006, 26 (11) : 1392 - 1392
  • [44] Oral lysine clonixinate in the acute treatment of migraine - A double-blind placebo-controlled study
    Krymchantowski, AV
    Barbosa, JS
    Cheim, C
    Alves, LA
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2001, 59 (01) : 46 - 49
  • [45] DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study
    Lipton, Richard B.
    Munjal, Sagar
    Brand-Schieber, Elimor
    Rapoport, Alan M.
    HEADACHE, 2018, 58 (05): : 676 - 687
  • [46] FLUNARIZINE IV IN THE ACUTE TREATMENT OF THE MIGRAINE ATTACK - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    SOYKA, D
    TANERI, Z
    OESTREICH, W
    SCHMIDT, R
    CEPHALALGIA, 1988, 8 : 35 - 40
  • [47] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY OF SUBCUTANEOUS SUMATRIPTAN IN GENERAL-PRACTICE
    RUSSELL, MB
    HOLMTHOMSEN, OE
    NIELSEN, MR
    CLEAL, A
    PILGRIM, AJ
    OLESEN, J
    CEPHALALGIA, 1994, 14 (04) : 291 - 296
  • [48] Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: A randomized, double-blind, double-dummy, crossover study
    Stronks, DL
    Tulen, JHM
    Bussmann, HBJ
    Mulder, LJMM
    Passchier, J
    HEADACHE, 2003, 43 (08): : 845 - 852
  • [49] Eletriptan vs sumatriptan:: a double-blind, placebo-controlled, multiple migraine attack study -: Reply
    Sandrini, G
    Färkkilä, M
    Forster, E
    NEUROLOGY, 2003, 60 (07) : 1222 - 1222
  • [50] A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine
    Winner, P
    Ricalde, O
    LeForce, B
    Saper, J
    Margul, B
    ARCHIVES OF NEUROLOGY, 1996, 53 (02) : 180 - 184
12345